School of Medicine
Showing 2,201-2,250 of 2,433 Results
-
Hannah Valantine
Professor of Medicine (Cardiovascular)
Current Research and Scholarly InterestsMy lab is focused on understanding the mechanism mediating acute and chronic allograft failure, in particular on the role of microvascular injury in acute allograft failure and the mechanisms of mediating transplant coronary artery disease. 1. Role of microvascular injury in acute allograft failure.
-
Laura van Dam
Postdoctoral Scholar, Immunology and Rheumatology
BioI am both trained as a biomedical researcher and medical doctor in internal medicine and strive to close the gap between the clinic and fundamental sciences with translational research. My focus is to study the mechanisms of autoimmune diseases and to translate research insights into therapeutics targeting autoimmunity. I have received my PhD in 2022 in Leiden for studying neutrophil extracellular traps and autoreactive B cells in renal autoimmune diseases. My postdoctoral research project in the Robinson lab focuses on investigating the underlying molecular mechanisms of the pathogenesis of ANCA-associated vasculitis. I particularly aim to identify potential microbial triggers and molecular mimicry in ANCA-associated vasculitis, by characterizing the nasal microbiome and sequencing T cells and B cells of ANCA-associated vasculitis patients.
-
Laurens van de Wiel
Postdoctoral Scholar, Cardiovascular Medicine
BioI am a post-doctoral researcher at Stanford University under supervision of Matthew Wheeler and Stephen Montgomery. My research focuses on understanding the entire spectrum of genetic variation effects on protein function and structure in order to decipher molecular mechanisms of disease.
My post-doctoral work centers on developing novel software methodologies which combine multi-omics data to interpret the functional impact of genetic variants in undiagnosed patients. I am part of the Undiagnosed Disease Network (UDN) at Stanford Center for Undiagnosed Diseases (CUD), Genomics Research to Elucidate the Genetics of Rare Diseases (GREGoR) consortium at GREGoR Stanford Site (GSS), and the Molecular Transducers of Physical Activity Consortium (MoTrPAC) at the Bioinformatics Center (BIC).
Before joining Stanford. I was received my Ph.D. in 2021 at the Radboud University Medical Center under supervision of Christian Gilissen, Gert Vriend, and Joris Veltman. I received my MSc degree in 2014 at Radboud University under supervision of Tom Heskes, Evgeni Levin, and Armand Paauw. Before my Ph.D, I worked as a Data Scientist at FLXone, where I developed machine learning solutions within a large-scale, real-time infrastructure.
Research
I am interested in a variety of topics in Bioinformatics and Computer Science. In particular, I am interested in the application of Artificial Intelligence and Statistical Modelling to analyse human (Rare) Mendelian Disease Genetics, Evolutionary Comparative Genomics, Protein Domain Homology, and Molecular Structures. -
Mark Van Orden
Postdoctoral Scholar, General Internal Medicine
BioMark Van Orden is a postdoctoral scholar at the Stanford School of Medicine. His research applies causal inference and natural experiments to questions at the intersection of economics and health. His current work examines how shingles vaccination affects brain structure using MRI data from the UK Biobank, providing the first causal neuroimaging evidence of how vaccination protects against dementia. He received his PhD in Economics from the University of California, Irvine.
-
Anubodh Sunny Varshney
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Anubodh Sunny Varshney is a Clinical Assistant Professor, Medical Director of Mechanical Circulatory Support, and Associate Director of the Fellowship Program in the Section of Advanced Heart Failure, Transplant Cardiology, and Mechanical Circulatory Support at Stanford. In addition to caring for patients with advanced heart disease, he is also a clinical researcher and works to identify patient groups that have sub-optimal outcomes with current therapies, define benchmark outcomes that next generation therapies should improve upon, and understand factors that influence adoption of novel drug and device therapies for cardiovascular disease.
Dr. Varshney earned a BS in biomedical engineering from Washington University in St. Louis and an MD from the University of Texas Southwestern Medical School. He completed residency in Internal Medicine and fellowship in Cardiovascular Medicine at Brigham & Women’s Hospital/Harvard Medical School and fellowship in Advanced Heart Failure, Transplant Cardiology, and Mechanical Circulatory Support at Stanford University.
Dr. Varshney also has experience advising multiple medical device, drug, and digital health start-ups and currently serves as a Venture Advisor at Broadview Ventures, a philanthropically-funded, mission-driven investment organization that invests in early-stage companies developing technologies that have the potential to improve outcomes for patients with cardiovascular disease or stroke. -
Shivam Vedak
Clinical Assistant Professor, Medicine
BioShivam Vedak, MD, MBA, is a Clinical Assistant Professor in the Division of Hospital Medicine at Stanford University School of Medicine. He earned his Bachelor of Science in Biology-Neuroscience from the Schreyer Honors College at The Pennsylvania State University, followed by a dual MD/MBA from the University of Illinois at Chicago (UIC). He completed his residency in Internal Medicine at UIC, where he was honored as the institution’s American College of Physicians Outstanding Resident of the Year in 2022, and subsequently completed a fellowship in Clinical Informatics at Stanford.
Clinically, Dr. Vedak practices as a surgical co-management hospitalist at Stanford Health Care (SHC). His academic and operational work centers on the practical integration of generative artificial intelligence (AI) into clinical workflows, ranging from safe and effective deployment and monitoring to the broader education of healthcare workers on these rapidly evolving technologies. He is frequently invited to speak at national conferences, academic institutions, and professional events, offering both engaging interactive workshops and structured didactic sessions on the fundamentals of large language models (LLMs) and evidence-based prompting techniques. -
Abraham Verghese, MD, MACP
Linda R. Meier and Joan F. Lane Provostial Professor, Emeritus
Current Research and Scholarly InterestsMy interest is in clinical skills and the bedside exam, both in its technical aspects, but also in the importance of the ritual and what is conveyed by the physician's presence and technique at the bedside. This work interests me from an educational point of view, and also from the point of view of ethnographic studies related to rituals and how they transform the patient-physician relationship. Recently we have become interested in medical error as a result of oversights in the bedside exam.
-
Maria Norma Villalon Landeros
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Norma Villalon's path to medicine reflects a journey of perseverance and community service. Born and raised in rural Guanajuato, Mexico, her early years were shaped by strong family bonds and a deep appreciation for community care, despite financial challenges. Before immigrating to the United States at 18, she dedicated herself to adult education through INEA, teaching literacy and basic education to members of her community. This early experience fostered her commitment to serving diverse populations and understanding their unique needs. As a first-generation professional from an immigrant background, Dr. Villalon brings a unique perspective to medicine, informed by her profound understanding of underserved communities. Her journey from a small Mexican village to becoming a physician exemplifies the power of determination and the importance of accessible healthcare. Through her work, she continues to advocate for equitable medical care while actively mentoring and supporting the next generation of physicians from underrepresented backgrounds.
-
Kathan Vollrath, MD, MPH
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr Vollrath is an internal medicine primary care physician at Stanford Internal Medicine Clinic. She provides asynchronous message-based care via myHealth, including inbox coverage for faculty on vacation. She is a QuEST scholar, studying the implementation of this new service.
-
Heather Wakelee
Winston Chen and Phyllis Huang Professor
Current Research and Scholarly InterestsDr. Wakelee's research is focused on clinical trials and translational efforts in patients with lung cancer and other thoracic malignancies such as thymoma and thymic carcinoma. Other interests include translation projects in thoracic malignancies and collaborations with population scientists regarding lung cancer questions.
-
Jared Andrew Wallace
Clinical Assistant Professor, Medicine - Hematology
BioDr. Wallace is a Clinical Assistant Professor in the Division of Hematology at Stanford University School of Medicine. He earned his MD and PhD in Molecular Biology from University of Utah in 2020 where he studied the role of non-coding RNAs in promoting the development of myeloid malignancies. He completed his Internal Medicine residency and fellowship in Hematology and Medical Oncology at Stanford. He specializes in the diagnosis, evaluation and treatment of hematologic malignancies, with particular emphasis on multiple myeloma and acute myeloid leukemia. His current research is focused on understanding the role of the bone marrow microenvironment in promoting the development and progression of hematologic malignancies.
-
Aileen Xinqian Wang
Clinical Assistant Professor, Medicine - Nephrology
BioPhilosophy of Care: dedicated to clear communication and teamwork approach to provide the best care possible to all patients.
Clinical Interests: focus on individualized evaluation/tailoring of clinical immunosuppression, management of mineral bone disease post kidney transplant, and the prevention/treatment of COVID-19 in kidney transplant recipients.
Research/Academic Interests: focus on optimization of immunosuppression regimen, mineral bone disease in kidney transplant recipients, delayed graft function outcomes, and COVID-19 infection in kidney transplant recipients.
